Henk van Wyk

Henk van Wyk

Chief Scientist

Mr Van Wyk brings over 40 years of experience in the pharmaceutical industry to the Reven team, including research, development, drug design and formulation.

Originally from South Africa, he directly oversaw the development of the first automated manufacturing facility for sterile intravenous fluids in South Africa which was ultimately awarded a “Technology Top 100” award by the Engineering Association of SA for innovation in the Medical/Pharmaceutical field. Mr. van Wyk was also a founding member of the South African Academy of Pharmaceutical Sciences. His groundbreaking research for new therapies in the treatment of PAD, Endothelial Dysfunction, CLI, Raynaud’s Disease, Buerger’s Disease and Coronary Arterial Disease are the foundation of the Reven product line.